Medine.co.uk

Tolterodine Tartrate 2 Mg Film-Coated Tablets

Informations for option: Tolterodine Tartrate 2 Mg Film-Coated Tablets, show other option
Document: leaflet MAH GENERIC_PL 10880-0120 change

PACKAGE LEAFLET: INFORMATION FORTHE USER


SZ00000LT000


Tolterodine Tartrate 1 mg film-coated Tablets Tolterodine Tartrate 2 mg film-coated Tablets

Tolterodine tartrate


Read all of this leaflet carefully before you start taking this medicine.

•    Keep this leaflet.You may need to read it again.

•    If you have any further questions, ask your doctor or your pharmacist.

•    This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

•    If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


In this leaflet:

1.    What Tolterodine tartrate is and what it is used for

2.    Before you take Tolterodine tartrate

3.    How to take Tolterodine tartrate

4.    Possible side effects

5.    How to store Tolterodine tartrate

6.    Further information



What Tolterodine tartrate is and what it is used for


Tolterodine tartrate is used to treat symptoms of overactive bladder, such as:

•    inability to control urination

•    need to rush to the toilet with no advance warning and/or go to the toilet frequently

Tolterodine tartrate belongs to a class of urologic muscle relaxants, which relax the bladder muscle.


The following medicines can influence or be influenced

by Tolterodine tartrate:

   medicines to treat irregular heart beat, such as quinidine, procainamide, amiodarone, sotalol

•    macrolide antibiotics, such as erythromycin, clarithromycin

•    medicines to treat fungal infections, such as ketoconazole, itraconazole

   medicines to treat HIV containing active substances with names ending in “-navir”

   metoclopramide, cisapride medicines to increase intestinal motility


Before you take Tolterodine tartrate


Do not take Tolterodine tartrate

if you are/have

   allergic (hypersensitive) to tolterodine tartrate or any of the other ingredients

   inability to empty the bladder

•    a chronic ulcerative and inflammatory bowel

disease (severe ulcerative colitis)

   increased eye pressure with loss of eyesight that is not being adequately treated (uncontrolled narrow-angle glaucoma)

•    a certain muscle weakness, called Myasthenia gravis

•    an acute enlargement of the colon (toxic megacolon)


Medicines with a similar mode of action (antimuscarinic properties) or medicines with an opposite mode of action (cholinergic properties) to Tolterodine tartrate could possibly interact with Tolterodine tartrate. Examples are:

•    medicines which dilate the eye pupil, such as atropine, scopolamine, tropicamid

•    medicines to lower pressure in the eye, such as carbachol, pilocarpine

•    medicines to treat Parkinson disease, such as biperiden, bornaprin, metixen, procyclidin, trihexyphenidyl

•    medicines to treat spasms of the stomach, bowel, bladder, genitals or the bronchial tubes, such as butylscopolaminium, ipratropium, tiotropium

•    medicines to treat bladder and bowel muscle disturbances, such as oxybutynin, trospium, solifenacin, darifenacin, bethanechol.


Take special care with Tolterodine tartrate

if you have

•    difficulty passing urine and poor urine output

•    a very swollen, painful stomach, affecting swallowing and digesting

•    kidney or liver problems

See chapter 3 “How to take Tolterodine tartrate”

•    a nerve problem which sometimes occurs with diabetes and can lead to diarrhoea, impotence or low blood pressure (Autonomic neuropathy)

•    Hiatus hernia, where part of your stomach protrudes through the diaphragm

•    have or previously have had severe constipation

•    a certain heart beat abnormality known as QT prolongation

•    abnormally low levels of potassium, magnesium or calcium in your blood

•    a pulse rate less than 60 beats per minute

•    heart diseases, such as heart muscle disturbance, reduced blood flow to the heart muscle, irregular heartbeat or heart failure

Please tell your doctor or pharmacist before taking

this medicine if any of the above apply to you.

Children, under 18 years

Tolterodine tartrate is not recommended for children.

Taking other medicines

Please tell your doctor or pharmacist if you are taking or

have recently taken any other medicines, including

medicines obtained without a prescription.


Pregnancy and breast-feeding

There is insufficient experience with the use of Tolterodine tartrate during pregnancy. As Tolterodine tartrate may harm your unborn child, you should not use Tolterodine tartrate when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant.

It is not known if the active substance in Tolterodine tartrate is excreted into mother's milk. Therefore, you should not take Tolterodine tartrate if you are breast-feeding.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Tolterodine tartrate may cause dizziness, fatigue and blurred vision. Do not drive or operate machinery if this affects you.


How to take Tolterodine tartrate


Always take Tolterodine tartrate exactly as your doctor has told you.You should check with your doctor or pharmacist if you are not sure.

The usual dose is: 2 mg twice daily (given as two 1 mg tablets or one 2 mg tablet twice daily)

Continued on the next page >>


In the case of impaired kidney or liver function or troublesome side effects the usual dose is 1 tablet twice daily.

Administration

Take the tablets whole with one glass of water independent of meals in the morning and in the evening.

Duration of use

To be decided by your attending doctor.

Do not stop treatment early because you do not see an immediate effect.Your bladder will need some time to adapt.Your doctor will evaluate the effect of your treatment after 2-3 months.

If you take more Tolterodine tartrate than you should

If you have taken too much Tolterodine tartrate, contact your doctor or pharmacist immediately.

If you forget to take Tolterodine tartrate

If you forget to take a dose, take the next dose normally, when it is due. Do not take a double dose to compensate the forgotten dose.

If you have any further questions on the use of this product, ask your doctor or pharmacist.


Not known, frequency cannot be estimated from available data

•    severe allergic reactions including swelling mainly of the face, tongue or throat, difficulty to swallow, hives and difficulty in breathing

•    hallucinations

•    confusion

•    disorientation

•    flushed skin


If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


How to store Tolterodine tartrate


Keep out of the reach and sight of children.

This medicinal product does not require any special storage conditions.

Do not use Tolterodine tartrate after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.


4 Possible side effects


Medicines should not be disposed via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


Further information


Like all medicines, Tolterodine tartrate can cause side effects, although not everybody gets them.

You should see your doctor immediately or go to the casualty department if you experience symptoms of angioedema such as

•    swollen face, tongue or throat

•    difficulty to swallow

•    hives and difficulty in breathing

Side effects can occur with the following frequencies:

Very common, occurs in more than 1 per 10 users:

•    dry mouth

This may occur in 35 % of patients.

•    headache

Common, occurs in 1 to 10 per 100 users:

•    constipation

•    abdominal pain

•    dizziness

•    sleepiness

•    decreased tear production, causing dry irritable eyes

•    fatigue

•    drowsiness

•    altered sensation - pins and needles

•    blurred vision

•    vertigo

•    chest pain

•    flatulence

•    vomiting

•    diarrhoea

•    pain or difficulty in passing urine

•    inability to empty the bladder

•    dry skin

•    palpitations

•    bronchitis

•    extra fluid in the body causing swollen hands, ankles and/or feet

•    increased weight

Uncommon, occurs in 1 to 10 per 1,000 users:

•    allergic reactions

•    heartburn

•    nervousness

•    memory impairment

•    increased heart activity

•    irregular heartbeat

•    heart failure


What Tolterodine tartrate contains

•    The active substance is tolterodine tartrate.

One tablet contains 1 mg of tolterodine tartrate, equivalent to 0.68 mg of tolterodine.

One tablet contains 2 mg of tolterodine tartrate, equivalent to 1.37 mg of tolterodine.

•    The other ingredients are:

Tablet core: cellulose, microcrystalline; calcium hydrogen phosphate, anhydrous; sodium starch glycolate (Type A); magnesium stearate; silica, colloidal anhydrous

Tablet coating: cellulose, microcrystalline; hypromellose; stearic acid; titanium dioxide (E171)


What Tolterodine tartrate looks like and contents of the pack

Tolterodine tartrate 1 mg tablets are white or almost white, round and biconvex film-coated tablets, coded with “1” on one side.

Tolterodine tartrate 2 mg tablets are white or almost white, round and biconvex film-coated tablets, coded with “2” on one side.


The film-coated tablets are supplied in blister packs or plastic bottles containing 7, 14, 28, 30, 50, 56, 60, 84, 98, 100 and 500 film-coated tablets.

Not all pack sizes or containers may be marketed.

Marketing Authorisation Holder and Manufacturer

MA Holder:

Hexal AG, Industriestrasse 25, 83607 Holzkirchen, Germany.

Manufacturer:

Salutas Pharma GmbH, Otto-von-Guericke- Allee 1, 39179 Barleben, Germany or

Salutas Pharma GmbH, Dieselstrasse 5,

70839 Gerlingen, Germany

or

Lek Pharmaceuticals d.d., Verovskova 57,

1526 Ljubljana, Slovenia or

LEK S.A., UI. Podlipie 16 C, 95010 Strykow, Poland or

LEK S.A., UI. Domaniewska 50 C, 02-672 Warsaw, Poland.


This leaflet was last approved in 08/2011 (to be

amended after approval).


SZ00000LT000